John Yager
Family Medicine · Spring City, TNNPI 1700248119
Payments from drug & device makers
Across 325 payments — averaging $16.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$744
- Lilly USA, LLC$743
- GSK$473
- Bayer$210
- Amgen$201
- plus $2K from 26 others
What the payments were for
- Food & beverage$5,297100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 65 | $1,102 |
| AbbVie | 54 | $744 |
| Lilly USA, LLC | 57 | $743 |
| GSK | 31 | $473 |
| Bayer | 12 | $210 |
| Amgen(2 entities) | 12 | $201 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $177 |
| AstraZeneca | 12 | $172 |
| UCB, Inc. | 2 | $157 |
| Boehringer Ingelheim | 8 | $131 |
| Xeris Pharmaceuticals, Inc. | 6 | $125 |
| Pfizer | 7 | $120 |
| Lundbeck LLC | 5 | $113 |
| Verona Pharma, Inc. | 3 | $90 |
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| Abbott | 4 | $84 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $80 |
| Dexcom, Inc. | 4 | $74 |
| Phathom Pharmaceuticals, Inc. | 4 | $67 |
| Inspire Medical Systems, Inc. | 2 | $49 |
| Johnson & Johnson | 3 | $48 |
| Antares Pharma, Inc. | 2 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Tolmar, Inc. | 2 | $31 |
| Eisai Inc. | 1 | $24 |
| Mylan Specialty L.p. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Medtronic | 1 | $18 |
| Cipher Pharmaceuticals US LLC | 1 | $17 |
| Exact Sciences | 1 | $15 |
| Merck | 1 | $14 |
| Boston Scientific | 1 | $14 |
How this compares
$5,303 in reported general payments places this provider in the 80th percentile of 2,087 family medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 222 | $294,124 |
| EliquisApixaban | 184 | $172,849 |
| OzempicSemaglutide | 116 | $153,433 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 126 | $138,860 |
| JardianceEmpagliflozin | 128 | $134,879 |
| TrulicityDulaglutide | 48 | $82,395 |
| XareltoRivaroxaban | 65 | $73,553 |
| CreonLipase/Protease/Amylase | 12 | $60,965 |
| FarxigaDapagliflozin Propanediol | 55 | $55,403 |
| RybelsusSemaglutide | 30 | $43,502 |
| RexultiBrexpiprazole | 24 | $34,627 |
| Spiriva HandihalerTiotropium Bromide | 21 | $22,753 |
| LinzessLinaclotide | 19 | $22,590 |
| Lupron DepotLeuprolide Acetate | 11 | $21,136 |
| JanuviaSitagliptin Phosphate | 16 | $20,128 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $743 | $376,519270 claims |
| Novo NordiskOzempic, Rybelsus | $1,102 | $196,935146 claims |
| PfizerEliquis | $120 | $172,849184 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $473 | $151,405142 claims |
| Boehringer IngelheimJardiance | $131 | $134,879128 claims |
| AbbVieCreon, Linzess, Lupron Depot | $744 | $104,69142 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $172 | $76,16981 claims |
| Johnson & JohnsonXarelto | $48 | $73,55365 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $89 | $34,62724 claims |
| MerckJanuvia | $14 | $20,12816 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Spring City
- Rickey ManningKnoxville$8.1M
- Kymberly MoyerGallatin$5.9M
- Natasha BallardChattanooga$5.7M
- Hina BudhwaniNashville$4.7M
- Paul WakefieldKnoxville$4.3M
- Emily HubbsKingsport$2.8M
- Jerry PunchKnoxville$2.1M
- Bridgette FraneyNashville$2M
- Andrew BrockmyreBristol$1.8M
- Marcus LeeTullahoma$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.